Algorytm mnie nie lubi, artykuł/teza o $IBRX prawie nie ma wyświetleń w porównaniu z innymi postami. Znajdziecie go przypiętego na moim profilu. Jeśli możecie, pomóżcie przebić się z zasięgiem i udostępnijcie. Dzięki!
Once in full production X MW per year 🤣 makes the most sense! no envioronmental issues, no protests, no tenant, free cooling & direct sun synchronous power.
According to Corruption Watch, South Africa went from being one of the least corrupt countries in the world in 1995, ranking alongside Belgium and Japan, to one of the most corrupt countries in the world, ranking alongside Cuba and Kazakhstan in 2026.
The one thing you can say about everyone who’s unhappy about Elon Musk’s new trillionaire status is that they’re the same bitter and resentful people who would hate you if you had more than them.
They make terrible friends
You shouldn’t do business with them
Never lend them money
Never marry them
Never give them any responsibility
💥Newsom. Sanders. Warren. Three politicians. Zero companies built. Combined wealth funded by lobbyists and donor cash.
Elon Musk dominated in: Payments. Cars. Energy. Space. Social Media. Communications. AI
He didn't just succeed he made America stronger.
And that's exactly why they hate him.
A fundamental truth that none of their supporters in this country will face is that @MYANC came to power to steal - period. They believed that years of fighting to end apartheid - despite contributing relatively little to its eventual demise - and decades spent in exile meant they were owed a debt. And they have been collecting that debt every day since 1994.
There is no room in South Africa for innovation, entrepreneurship, or development that benefits the country and its people at large.
Theft and destruction are so deeply entrenched in the ANC's DNA that they have become its defining characteristics.
The overwhelming majority of South Africa's new billionaires owe their fortunes to political patronage, B-BBEE rent seeking, and/or outright theft.
Please stop the madness! The USA is supposed to take care of their citizens over and above anything else. Fast track # ANKTIVA for all cancer patients to help us fight this terrible disease. Lives over profit for Big Pharma. @POTUS@SecKennedy@FDA_KyleD
It is time to celebrate actually.
It means that there's no ceiling to success.
That anyone can come to America, make insanely valuable stuff, and then reap the rewards of that effort through free market dynamics that reward the best product or service.
Elon Musk was not handed what he owns today, he built every bit of it from absolute scratch.
The trillion dollars everyone is talking about did not just sit in a giant vault waiting for him to open it and grab it.
He had to create that value entirely from nothing.
If Elon Musk had never existed, nobody would have his trillion dollars, because that wealth would not exist either.
That wealth would not exist at all, because the revolutionary technologies and industries he created wouldn't exist either.
Instead of hating on his historic success, people should be deeply inspired by it.
We are incredibly fortunate to be alive at the exact same time as him.
He is an exceptional human being, and your great-grandchildren will find it hard to believe that such a legendary figure actually walked the earth in our lifetime.
🚀 @SpaceX listing today.
Me as a kid: “I want to be an astronaut.”
Me as adult: “I want astronaut exposure in my portfolio.”
https://t.co/LP6qI3g3p8 | #EasyEquities
FDA is extending the comment period for the Request for Information on Drug Repurposing for Unmet Medical Needs by 30 days — now open until July 11, 2026! https://t.co/HEI7jGG6Km
Plus, join us for a hybrid public workshop on drug repurposing on August 5 that will cover public docket comments & approaches for prioritizing and selecting repurposing candidates. Stay tuned for registration details. https://t.co/RrbxhUjkzn
$IBRX (ImmunityBio) — As a former physician, this is one of the most undervalued oncology assets I’ve seen in years.
Countless cancer patients run out of options while their immune systems were destroyed by chemo and radiation. $IBRX is the right medicine to restore their immune system.
Proven Mechanism (FDA-Validated):
ANKTIVA is the world’s first IL-15 superagonist. It selectively activates NK cells, CD8+ killer T-cells, and CD4+ helper T-cells while generating durable memory T-cells — without stimulating suppressive Tregs. The NCI ranked IL-15 #1 as the most promising molecule for curing cancer. The science here is exceptional.
Compelling Clinical Data:
• In BCG-unresponsive NMIBC with papillary disease: 12-month DFS 58.2%, 3-year disease-specific survival 96%, and 81.8% bladder preservation at 3 years — over 80% of patients avoided radical cystectomy. Long-term data published in Journal of Urology.
• In advanced NSCLC after checkpoint failure: median OS 14–21+ months (well beyond historical controls of ~9 months), with some patients alive 4+ years later and clear immune restoration (reversing lymphopenia). Strong data continues at ASCO 2026.
Commercial traction is real and accelerating:
Full-year 2025 net product revenue reached $113 million (+700% YoY) with 750% unit growth.
Q1 2026 delivered a record $44.2 million (+168% YoY, +15% QoQ). Sales momentum is building every single quarter.
Why it’s so undervalued:
Approved or authorized across ~34 countries (US, EU, UK, Saudi Arabia — including first lung cancer approval in Saudi).
Pipeline is advancing rapidly: sBLA for papillary NMIBC on track, BCG-naïve pivotal trial fully enrolled, NSCLC Phase 3 ongoing, plus programs in glioblastoma, pancreatic, lymphoma, and lymphopenia.
Current market cap ~$7.25B with the stock still near $7.
Analyst average target ~$14.20 (highs to $23+). With revenue scaling and label expansions, the real intrinsic value is significantly higher.
This isn’t just another biotech story — it’s a commercial-stage immunotherapy platform with 5–10x potential still trading near $7.
$IBRX ANKTIVA has the mechanism, the data, the approvals, and now the commercial ramp. Real patient demand is here and growing.
Big Pharma can’t suppress this forever. Dr. Patrick Soon-Shiong’s team is executing hard. Catalysts are lined up. $IBRX 🚀
(Former physician perspective. Not financial advice — always do your own research and DYOR!)